Saturday 17 October 2026 Export CTMX’s income statement to Excel — free account

CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $76.2 million, down 44.8% from fiscal 2024. In the quarter to June 2026, revenue fell 92.4%, EPS fell 7,400.0% and free cash flow fell 14.5%, each against the same quarter a year earlier.

2.27 0.14 −5.81%

Follow CTMX

Alert me

Market cap: $525.1M
P/E: 0.0×
Fwd P/E: −6.9×
Dividend yield: —
F-score: 2/9
Altman Z: 0.92
Beneish M: −1.09
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	8.00	+8 more quarters Free account
P/S ratio Full definition →	44.86	23.44	7.71	4.63
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(45.44)	(32.61)	(25.28)	(33.85)
P/B ratio Full definition →	2.72	2.60	5.93	4.90
Price to Tangible BV Full definition →	2.73	2.62	6.02	4.97
EV/Sales Full definition →	26.99	13.80	5.97	3.40
EV/EBITDA Full definition →	0.00	0.00	0.00	17.38
EV/Operating CF Full definition →	(5.99)	(6.12)	(6.01)	(5.35)
EV/FCF Full definition →	(5.98)	(6.11)	(6.00)	(5.35)
Quick Ratio Full definition →	9.25	10.21	2.98	3.54
Current Ratio Full definition →	9.36	10.38	3.09	3.64
Net Debt/EBITDA Full definition →	13.16	17.21	4.87	8.83
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.07	0.16	0.56	0.76
Operating CF/Net income Full definition →	0.87	1.40	0.79	1.09
Capex/Depreciation Full definition →	0.00	0.00	0.96	(0.25)
Research and Development Expense of Revenue Full definition →	1,241.04%	187.54%	3,202.71%	256.65%
Selling, General and Administrative Expense of Revenue Full definition →	536.04%	104.23%	1,110.11%	107.78%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.01	0.01
Share Based Compensation of Revenue Full definition →	181.73%	45.88%	223.08%	23.21%
Graham Net Nets Full definition →	0.36	0.38	0.16	0.19
Graham Number Full definition →	0.00	0.00	0.00	2.42
Earnings Yield Full definition →	(13.33%)	(8.75%)	(0.97%)	12.50%
Free Cash Flow Yield Full definition →	(10.06%)	(9.64%)	(12.90%)	(13.75%)
Revenue per Share Full definition →	0.01	0.06	0.00	0.04
Operating CF per Share Full definition →	(0.08)	(0.14)	(0.17)	(0.09)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.08)	(0.14)	(0.17)	(0.09)
Cash per Share Full definition →	1.51	1.96	0.99	0.87
Shareholders Equity per Share Full definition →	1.38	1.80	0.72	0.65
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.38	1.80	0.72	0.65
Free Cash Flow Full definition →	(18.07)	(25.55)	(23.44)	(15.42)
Working Capital Full definition →	333.29	319.07	97.31	108.19
Capital Expenditures Full definition →	—	—	(0.20)	0.13
Net Current Asset Value Full definition →	294.00	313.68	91.36	98.35
EV/EBIT Full definition →	0.00	0.00	0.00	16.64
Capex to Sales Full definition →	0.00	0.00	0.30	(0.02)
Price to Operating Income Full definition →	0.00	0.00	0.00	22.64
Other line items
Average Receivables Full definition →	19.68	1.30	2.56	2.49
Average Payables Full definition →	1.08	0.82	1.19	1.03
Average Assets Full definition →	278.14	228.93	136.05	148.62
Average Common Equity Full definition →	210.99	172.50	49.28	41.97

Show all line items

Columns are period end dates

Stockrow Weekly